oxfordbiotherapeutics

About oxfordbiotherapeutics

Oxford Biotherapeutics (OBT) is a clinical-stage biotechnology company focused on developing innovative antibody-based therapeutics for the treatment of cancer. The company utilizes its proprietary OGAP® platform, which is the world’s largest cancer-specific membrane protein library, to discover novel, highly tumour-specific antigens for first-in-class ADC, Bispecific T-cell Engager (BITE®), and CAR-based therapeutics.

Career Opportunities

Oxford Biotherapeutics offers a dynamic working environment that fosters professional growth and collaboration among scientists and engineers. Employees are encouraged to contribute to cutting-edge research and drug discovery processes, supported by a strong internal and partnered pipeline with industry leaders.

• Private health care
• Generous pension scheme
• Annual training budgets